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Abstract—Metastasis is a complex and multi-step
stochastic process. The study of the probabilities of
generating a tumor from a primary site in another
organs is the aim of this work. Based on statistics of
National Institute of Cancer of Argentina (INC), a
characterization of the routes of metastasis for the
principal organs is presented by using Absorbing
Markov chains. The metastasis propagation from
different primary sites towards secondary and ter-
tiary sites is also shown, emphasizing the relation
and analysis about absorbing states.
Keywords-Metastasis; Complex Systems; Mathe-
matical Modelling; Absorbing Markov chains
I. INTRODUCTION
Cells have a specific and stipulated time
of death (apoptosis) and reproduction rate to
maintain cell balance. A tumor is the result of an
uncontrolled growth of abnormal cells or when
cells lose the ability to die. These cells form
accumulations that affect the normal functioning
of the organs, and can spread to other organs so
as to cause metastasis. Metastasis is the spread of
circulating tumor cells (CTC) from a primary site
to near or distant locations by different ways. This
depends on the organ and its initial localization
through either the bloodstream or the lymphatic
system (a collection of vessels that carry fluid
and immune cells)[1], [2].
Markov chains are used to model different
natural systems based on statistics and applications
([3], [4]), making the dynamic and continuous
processes where the states depend only on the
actual state and not as a result of previous
events[5]. Recently, some works ([6], [7]) give
different approaches by using Markov chains
in metastasis processes from the lung, where
mechanisms of progression and time scales of
systemic disease are quantized. In the present
work, we use absorbing Markov chains to analyse
the metastasis transmission of solid tumors of
different organs: from the primary site to a
secondary site (called metastasis from primary
site), and from there to a tertiary site (metastasis
of secondary site) for the principal cancers in
Argentina. The probabilities of having a tumor in
a tertiary or secondary site from a primary site
and their differences depending on each organ is
analysed, as well as the probabilities that from a
primary site ends in those organs that have very
low probability of spreading CTCs are calculated.
Finally, the steps (meaning the stages between
metastasis from a primary to secondary or tertiary
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site) based in absorbing states (in our case, organs
with low probability of generating metastasis)
are found. The aim of the present work is to
understand how the organs are related to each
other giving a characterization of the routes of
metastasis.
The metastasis are different for males and fe-
males. However the analysis performed here is
similar in both cases, although different organs are
affected (ovaries, vagina or uterus in females and
prostate or testicles in males). In this paper we
refer only the metastasis in males as a case study.
This work is organized as follow: In Section
II a brief description of the methodology is
given; Section III is devoted to describe transition
matrices and absorbing states; The transition
matrix for tertiary sites is shown in Section IV;
An analysis of expected number of steps and
probability of absorption by absorbing states
is found in Section V; Finally, comments and
conclusions are drawn in Section VI.
II. METHODOLOGY
The Markov chain transition matrix P was
assembled and it is determined by the number
of organs with higher probabilities of developing
metastasis. This matrix shows the probability that
an organ can be reached by CTCs[8] from another
organ and has been built under the assumption of
developing metastasis. Up to now, three leading
routes of metastasis are known: Hematogenous
(blood circulation), lymphatic and transcoelomic.
With this information, the statistics of National
Institute of Cancer of Argentina[9] of the principal
tumors and quantitative data on the main organs
affected depending on the primary site (obtained
from National Cancer Institute at the National
Institutes of Health of United States)[10], we
performed the graph (depicted in Fig. 1) showing
the most common tumors and the principal sites
where they can generate metastasis.
The graph was designed by free software
Visone 2.15[11]. The size of the nodes represents
Fig. 1: Graph for the principal links of metastasis
for tumors in males based in statistics. The name
of the organs were referred by a symbol as de-
picted in Table I.
the proportion of cases for the main tumors
mentioned in reference [9]. The connection of
these nodes (the links) is based on the main sites
of metastasis, for each specific organ, according to
the data of the reference [10]. Besides, the shapes
of the nodes depends on the amount of linked
organs: Circle, 6 or more organs to propagate
metastasis; Rhombuses, 4 or more; Hexagons, 2
or more; and finally Octagons, organs with low
probability of propagate metastasis. It is important
to note that the organs with low probability of
generating metastasis, compared to the rest, are
shown in the graph as a link on themselves (not to
be confused as to metastasize about themselves).
In Fig. 1, it can be seen that the Lung is the
principal link. Although the principal primary
sites are Prostate, Colon or Rectum, Lung tumor
is the most common but usually comes from
some primary site, being the principal secondary
site ([12], [13]).
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TABLE I: Symbols for organs
ORGAN NAME
Adrenal Gland A
Bladder Bl
Bone Bo
Brain Bra
Breast Bre
Colon/Rectum CR
Gallbladder G
Kidney K
Liver Li
Lung L
Melanoma M
Pancreas Pa
Peritoneum Pe
Prostate Pr
Skin/Muscle SM
Stomach St
Testicular Te
Thyroid Th
III. TRANSITION MATRIX, PROBABILITIES AND
ABSORBING STATES
A. Transition matrix and its probabilities
The characterization of metastatic evolution is
developed by using Markov chains, based on a
network construction from a primary site.
Let X0 (primary site) be the organ where the
tumor was originated, and X1 the state of the pro-
cess where the new tumor is formed coming from
the primary site and develop metastasis (Note: The
transition time, sub index of X , does not refer
to a calendar time, it refers to a general time in
which has already been observed a new tumor).
The probability that an organ develops metastasis
from another one is:
pij = P [X1 = j|X0 = i] (1)
where i, j = 1, 2, 3...,m number of organs.
The values pij are called transition probabili-
ties[14] and have two properties:
•
∑m
j=1 pij = pi1 + pi2 + . . . + pim = 1, since
the system must be in one of these states m,
the sum of probabilities must be equal to 1.
This means that the elements in any row of
the matrix transition must add 1.
• Each element pij ≥ 0
Based in the transition probabilities, the transi-
tion matrix P is given by:
P = [pij ], P ∈ Rm×m (2)
The routes for metastasis from one organ to
another are known; although, in the literature,
no information is available about their relative
likelihood on which organs have an advantage over
others. Given this slight uncertainty, the qualitative
information ([10], [15]), we assume an equal prob-
ability that an organ X0 (primary site), reaches
other one X1 (secondary site), this is under the
assumption a metastasis is detected and based
in the possibles routes as previously discussed.
For other cases, where there are not predominant
organs for metastasis from a specific primary site
(according references [10], [12] and [13]), we will
assume zero probability in order to work only the
predominant sites of metastasis.
Looking at matrix P , if a tumor of a primary
site, for example Prostate (Fig. 3a), has a non
null probability of developing a new tumor in a
secondary site, this will be 1/4 for L, Li, Bo
and Pe. The same considering a tumor in Stomach
(3b), that probability will be 1/3 for Li, Pe and
L.
The matrix P is given in the Appendix
A. Another way to visualize the matrix P is
displayed in the Fig. 2, where, in RGB scale,
the probabilities expressed in Eq. 2 can been seen.
B. Absorbing states
It is worth to notice the existence of absorbing
states in the system, these are states where it is
impossible to leave and are found if any row of
the matrix satisfies[14]:
pii = 1 and pij 6= 0 (if i 6= j) (3)
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Fig. 2: Visualization of the transition matrix, in
gray scale, for secondary sites.
The properties of an Absorbing Markov chain
are:
• At least, it has one absorbing state
• The absorption ends in an absorbing state
with probability 1
In this work, the transition matrix was per-
formed from the principal organs with higher
probability for developing metastasis. However,
for some organs, if the tumor is originated there
or if it is developed elsewhere (first or secondary
sites), do not evolve as metastasis from there. The
absorbent states are organs that rarely metastasize,
i.e. these are organs do not generate metastasis
in the next step of the transition matrix. The
Absorbing States of P are: Bone (Bo), Brain
(Bra), Liver (Li), Peritoneum (Pe), Adrenal
Gland (A) and Skin/Muscle (SM ).
IV. TRANSITION MATRIX FOR TERTIARY SITES
(SECOND METASTASIS)
For the process to move from state i to state j
in two steps, it must go through an intermediate
state k. If a tumor in a secondary site spreads to
a new organ (tertiary site), this will be labelled as
X2. The probability of generate a new tumor in a
tertiary site from a primary site is given by:
p
(2)
ij = P [X2 = j|X0 = i] =
m∑
k=1
pik.pkj (4)
Li
Bo
Pr
25%
55
25%
;;
25%
))
25% // L
Pe
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St
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((
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Li
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Fig. 3: Probabilities (in percentage) of metastasis
in organs from Prostate (a) and Stomach (b) cancer
respectively.
where i, j, k = 1, 2, 3...,m number of organs.
Similarly Eq. 2, the new transition matrix for
Second Step P (2) is built for males and this is
given by:
P (2) = [p
(2)
ij ], P
(2) ∈ Rm×m (5)
Eq. 5 gives information how to obtain a second
metastasis from the original tumor going through
the possible connections. Although the metastasis
from metastasis is unlikely, some clinical evidence
was found in cites [16], [17]. The matrix P (2) is
shown Appendix B.
Therefore, P (2) allows to find the probabilities
of metastasis in a tertiary site from a primary site.
For sake of clarity, examples are shown in Fig. 4a
and 4b.
A global analysis of the matrix P (2) shows
that if the primary site is the Lung (L), absorbing
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Fig. 4: Probabilities (in percentage) for tumors in
tertiary site from (a) Colon/Rectum (CR) and (b)
Lung (L).
states are the most probable tertiary sites as
discussed in Sec. 3 (Bo,Bra, Li, Pe,A and
SM ). This remarks the role of Lung as the
principal link between organs[18]. For other
organs (disregarding the absorbing states), if the
tumor is developed, there is some probability to
generate metastasis in a tertiary site.
In sum, according with recent statistics[8],
the principal tumors in the population are Lung
(L) and Colon/Rectum (CR) tumor. In the
P matrix can be observed the probabilities
for evolving a tertiary site tumor from those
two. If Colon/Rectum tumor is a primary site,
the principal tertiary sites are Liver (Li) and
Peritoneum (Pe). And, if there is a Lung tumor,
the principal tertiary sites are the absorbing
states (Bo,Bra, Li, Pe,A and SM ), as it was
previously discussed. This can be visualized in
the Fig. 5.
Fig. 5: Visualization of the transition matrix, in
gray scale, for tertiary sites.
V. ANALYSIS OF THE EXPECTED NUMBER OF
STEPS AND PROBABILITY OF ABSORPTION BY
ABSORBING STATES
When the processes are absorbing, the number
of steps before the system is absorbed, as well
as, the probability of absorption of any absorbing
state can be found. In order to find this process,
each transition matrix will be represented in its
canonical form[14], called J . It is composed by
4 sub-matrices: N (this sub-matrix contains the
probabilities are moving from a non-absorbing
state to another non-absorbing state), A (sub-
matrix that contains the probabilities of going from
a non-absorbing state to another absorbing state),
O (zero sub-matrix) and I (identity sub-matrix).
J=
(
N A
O I
)
The matrices with smaller probability contain
elements that originate a absorbing states and n
non-absorbing states. There are a + n = m states
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of the system.
Let be the fundamental matrix F = I + N +
N2+· · · = (I−N)−1[14]. We can calculate from a
transient state the expected number of steps before
being absorbed by an absorbing state. Let ti be
the expected number of steps before the chain is
absorbed when this begins in a transient state i,
and let t¯ be the column vector whose i− th entry
is ti. Then, the vector t¯ can be estimated by the
following expression[14]:
t¯ = F. c¯ (6)
where c¯ is vector whose entries are all one.
t¯ =

steps
L 2.237
Bre 1.559
Bla 2.810
St 1.745
Th 2.810
M 1.447
K 2.118
Pr 1.559
CR 1.745
Pa 1.745
Te 1.745
G 1.745

In t¯ are shown the tumors with more than one
stage of metastasis (given the nearest integer,
one stage or a step is the first metastasis in
a secondary site, and two steps is the second
metastasis in a tertiary site). Bladder and Thyroid
have a higher number of steps, Lung and Kidney
have the maximal steps around two, this coincides
with the main trend of mortality in males due to
these tumors[12], [21].
In addition, the probability of absorption of any
non-absorbing state by any absorbing states can be
calculated, and this is given by[14]:
Z = F.A (7)
Z =
Bo Bra Li Pe A SM
L 0.190 0.120 0.283 0.169 0.133 0.10
Bre 0.297 0.280 0.320 0.042 0.033 0.025
Bla 0.164 0.128 0.322 0.197 0.068 0.118
St 0.063 0.040 0.427 0.389 0.044 0.033
Th 0.164 0.128 0.322 0.197 0.068 0.118
M 0.238 0.224 0.256 0.033 0.026 0.220
K 0.095 0.060 0.141 0.084 0.566 0.050
Pr 0.297 0.030 0.320 0.042 0.283 0.025
CR 0.063 0.040 0.427 0.389 0.044 0.033
Pa 0.063 0.040 0.427 0.389 0.044 0.033
Te 0.063 0.040 0.427 0.389 0.044 0.033
G 0.063 0.040 0.427 0.389 0.044 0.033

Here, the matrix Z shows the probability that
a specific organ (not belonging to the absorbing
states) is absorbed by an absorbing specific organ.
If we take as a reference the estimated sum of
all elements of each column (i.e., each absorbing
state), the main probabilities are Liver(Li) and
Bones (Bo), following by Peritoneum (Pe) and
Adrenal Gland (A).
VI. CONCLUSIONS
In order to search new ways to understand
the metastasis process and its interactions among
organs sites of possible metastasis, Absorbing
Markov chains were used as a mathematical tool to
achieve this goal. A characterization of the route of
metastasis was developed. The Lung as the main
connector between the primary site and the tertiary
site, with defined probabilities in emphasized.
The graphs and their connections, in order to
develop the transition matrices for the occurrence
of tumors, are a good approximation to the reality.
These matrices exhibit the connections and the
existence of absorbing states in organs with lower
probabilities (almost null) to generate metastasis
([19], [20]) in secondary sites, absorbing states
represent organs that are not the source of
metastasis (sponges as Newton calls in [6]).
By the analysis of the expected steps number
and the probability of absorption by absorbing
states, it is possible to predict the tertiary sites
from the secondary sites[22] (or at least estimated
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them). Furthermore, a quantized approximation
of the transition matrices of second step P (2) can
be obtained. It is a result useful for treatments
and therapies given its predictive character. Also,
we know that as we get more data on statistics
of metastasis, our analysis will be more accurate.
This can be through statistical methods or by
predominant tumor cells (Stems, progenitors
or differentiated) prevailing in each organ (or
migrated from other organs such as CTCs). The
latter is our immediate study object.
On the other hand, by the properties of
Absorbing Markov chains, it was found that
in no more than 2 steps (second metastasis in
tertiary site) any absorbing states are reached:
Bo,Bra, Li, Pe,A and SM as can be seen in
the references [23], [24], [25], [26] and [27]. This
also can be seen as a result from the point of
view of our model, the main point is the fact that
in 3 steps (P 3), we reach an absorbing state with
a high probability (see Appendix C), where the
sum of probabilities of each row, in the columns
of absorbing organs, is near to 1.

∑6
abs=1 pabs
L 0.845
Bre 0.928
Bla 0.790
St 0.905
Th 0.790
M 0.943
K 0.857
Pr 0.928
CR 0.905
Pa 0.905
Te 0.905
G 0.905

Where abs = Bo, Bra, Li, Pe, A and SM (The absorbing
states).
This analysis is quite similar for females,
taking into account the specific organs (Ovaries,
Vagina and Uterus).
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APPENDIX
A. Matrix P : Probabilities to generate metastasis in a secondary site from a primary site.
P =

L Bre Bla St Th M K Pr CR Pa Te G Bo Bra Li Pe A SM
L 0 1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
1
17
Bre
1
4
0 0 0 0 0 0 0 0 0 0 0 1
4
1
4
1
4
0 0 0
Bla
1
3
0 0 1
3
0 1
3
0 0 0 0 0 0 0 0 0 0 0 0
St
1
3
0 0 0 0 0 0 0 0 0 0 0 0 0 1
3
1
3
0 0
Th
1
3
0 0 1
3
0 1
3
0 0 0 0 0 0 0 0 0 0 0 0
M
1
5
0 0 0 0 0 0 0 0 0 0 0 1
5
1
5
1
5
0 0 1
5
K
1
2
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
2
0
Pr
1
4
0 0 0 0 0 0 0 0 0 0 0 1
4
0 1
4
0 1
4
0
CR
1
3
0 0 0 0 0 0 0 0 0 0 0 0 0 1
3
1
3
0 0
Pa
1
3
0 0 0 0 0 0 0 0 0 0 0 0 0 1
3
1
3
0 0
Te
1
3
0 0 0 0 0 0 0 0 0 0 0 1
3
0 1
3
0 0 0
G
1
3
0 0 0 0 0 0 0 0 0 0 0 1
3
0 1
3
0 0 0
Bo 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Bra 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Li 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Pe 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
SM 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1

B. Matrix P (2): Probabilities to generate metastasis in a tertiaryy site from a primary site.
P (2)=

L Bre Bla St Th M K Pr CR Pa Te G Bo Bra Li Pe A SM
L
53
255
0 0 2
51
0 2
51
0 0 0 0 0 0 71
510
29
340
101
510
2
17
7
68
6
85
Bre 0 1
68
1
68
1
68
1
68
1
68
1
68
1
68
1
68
1
68
1
68
1
68
9
34
9
34
9
34
1
68
1
68
1
68
Bla
8
45
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
22
255
22
255
151
765
20
153
1
51
22
255
St 0 1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
6
17
6
17
1
51
1
51
Th
8
45
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
22
255
22
255
151
765
20
153
1
51
22
255
M 0 1
85
1
85
1
85
1
85
1
85
1
85
1
85
1
85
1
85
1
85
1
85
18
85
18
85
18
85
1
85
1
85
18
85
K 0 1
34
1
34
1
34
1
34
1
34
1
34
1
34
1
34
1
34
1
34
1
34
1
34
1
34
1
34
1
34
9
17
1
34
Pr 0 1
68
1
68
1
68
1
68
1
68
1
68
1
68
1
68
1
68
1
68
1
68
9
34
1
68
9
34
1
68
9
34
1
68
CR 0 1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
6
17
6
17
1
51
1
51
Pa 0 1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
6
17
6
17
1
51
1
51
Te 0 1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
6
17
1
51
6
17
1
51
1
51
1
51
G 0 1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
1
51
6
17
1
51
6
17
1
51
1
51
1
51
Bo 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Bra 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Li 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Pe 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
SM 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
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C. Matrix P (3)
P (3)=
L Bre Bla St Th M K Pr CR Pa Te G Bo Bra Li Pe A SM
L
16
765
5
409
5
409
5
409
5
409
5
409
5
409
5
409
5
409
5
409
5
409
5
409
18
113
55
522
43
186
1
7
41
356
33
364
Bre
49
943
0 0 1
102
0 1
102
0 0 0 0 0 0 268
941
35
129
183
611
1
34
7
272
3
170
Bla
53
765
8
765
8
765
2
85
8
765
2
85
8
765
8
765
8
765
8
765
8
765
8
765
21
170
19
180
15
59
41
255
3
67
77
765
St
53
765
0 0 2
153
0 2
153
0 0 0 0 0 0 20
431
23
809
244
611
19
51
7
204
2
85
Th
53
765
8
765
8
765
2
85
8
765
2
85
8
765
8
765
8
765
8
765
8
765
8
765
21
170
19
180
15
59
41
255
3
67
77
765
M
18
433
0 0 2
255
0 2
255
0 0 0 0 0 0 18
79
28
129
98
409
2
85
7
340
91
425
K
53
510
0 0 1
51
0 1
51
0 0 0 0 0 0 41
589
29
680
91
919
1
17
75
136
3
85
Pr
49
943
0 0 1
102
0 1
102
0 0 0 0 0 0 268
941
10
469
183
611
1
34
75
272
3
170
CR
53
765
0 0 2
153
0 2
153
0 0 0 0 0 0 20
431
23
809
244
611
19
51
7
204
2
85
Pa
53
765
0 0 2
153
0 2
153
0 0 0 0 0 0 20
431
23
809
244
611
19
51
7
204
2
85
Te
53
765
0 0 2
153
0 2
153
0 0 0 0 0 0 20
431
23
809
244
611
19
51
7
204
2
85
G
53
765
0 0 2
153
0 2
153
0 0 0 0 0 0 20
431
23
809
244
611
19
51
7
204
2
85
Bo 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
Bra 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0
Li 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Pe 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0
SM 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1
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